Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 29.79%2.91B | ---- | -44.41%2.24B | ---- | -30.90%4.03B | ---- | -12.90%5.84B | ---- | -1.32%6.7B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 59.73%-252.41M | ---- | 7.29%-626.74M | ---- | -32.27%-676.04M | ---- | -6.71%-511.12M | ---- | 22.51%-478.98M | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | 99.64%-54K | ---- | 0.07%-15.07M | ---- | 19.20%-15.08M | ---- |
| Attributable subsidiary (profit) loss | 113.51%25.62M | ---- | -306.44%-189.65M | ---- | 191.68%91.87M | ---- | 124.50%31.5M | ---- | 18.73%-128.56M | ---- |
| Impairment and provisions: | -6.94%610.79M | ---- | 734.51%656.33M | ---- | -119.97%-103.44M | ---- | 218.43%518.04M | ---- | -443.51%-437.42M | ---- |
| -Impairment of property, plant and equipment (reversal) | -2.26%558.36M | ---- | 426.41%571.28M | ---- | -136.31%-175.02M | ---- | 277.34%481.95M | ---- | 337.63%127.72M | ---- |
| -Impairment of trade receivables (reversal) | -41.11%50.09M | ---- | 18.83%85.06M | ---- | 98.33%71.58M | ---- | 105.34%36.09M | ---- | -2,427.54%-675.59M | ---- |
| -Impairment of goodwill | --2.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --110.45M | ---- |
| Revaluation surplus: | -2,110.33%-120.88M | ---- | -103.02%-5.47M | ---- | 47.35%180.91M | ---- | 299.46%122.77M | ---- | -140.36%-61.55M | ---- |
| -Fair value of investment properties (increase) | -228.71%-85.84M | ---- | -73.34%66.69M | ---- | 48.42%250.16M | ---- | 29,679.15%168.55M | ---- | -99.77%566K | ---- |
| -Other fair value changes | 51.43%-35.05M | ---- | -4.20%-72.16M | ---- | -51.27%-69.25M | ---- | 26.30%-45.78M | ---- | 31.51%-62.12M | ---- |
| Asset sale loss (gain): | 150.17%70.17M | ---- | -2,039.83%-139.86M | ---- | -81.19%7.21M | ---- | 118.57%38.33M | ---- | -166.22%-206.39M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | -1,051.45%-184.65M | ---- | -470.35%-16.04M | ---- | --4.33M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 131.37%59.96M | ---- | 25.48%25.92M | ---- | 283.90%20.65M | ---- | -27.74%5.38M | ---- | 111.27%7.45M | ---- |
| -Loss (gain) from selling other assets | -45.90%10.21M | ---- | 627.97%18.87M | ---- | -90.94%2.59M | ---- | 113.38%28.62M | ---- | -792.70%-213.84M | ---- |
| Depreciation and amortization: | 102.55%1.42B | ---- | -6.28%699.48M | ---- | -1.43%746.36M | ---- | 22.40%757.2M | ---- | -8.76%618.64M | ---- |
| -Other depreciation and amortization | 144.88%1.24B | ---- | -1.30%505.35M | ---- | -8.99%511.99M | ---- | 24.22%562.57M | ---- | -4.54%452.89M | ---- |
| Financial expense | -32.57%1.07B | ---- | -0.63%1.58B | ---- | -0.73%1.59B | ---- | 4.54%1.61B | ---- | -17.31%1.54B | ---- |
| Special items | 806.24%6.11M | ---- | -513.48%-865K | ---- | 99.98%-141K | ---- | -25.79%-614.04M | ---- | 7.12%-488.16M | ---- |
| Operating profit before the change of operating capital | 35.92%5.73B | ---- | -28.17%4.22B | ---- | -24.41%5.87B | ---- | 10.38%7.77B | ---- | -16.09%7.04B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -2,082.46%-28.87M | ---- | -330.89%-1.32M | ---- | -36.05%573K | ---- | 116.53%896K | ---- | 44.54%-5.42M | ---- |
| Developing property (increase)decrease | 24.95%17.57B | ---- | 1,037.26%14.06B | ---- | 145.86%1.24B | ---- | 80.63%-2.7B | ---- | -18.46%-13.91B | ---- |
| Accounts receivable (increase)decrease | 302.37%1.18B | ---- | -278.47%-581.49M | ---- | -89.05%325.81M | ---- | 2,581.16%2.97B | ---- | 96.75%-119.9M | ---- |
| Accounts payable increase (decrease) | 33.92%-3.92B | ---- | -8,614.55%-5.93B | ---- | 102.07%69.6M | ---- | -680.93%-3.37B | ---- | -22.23%579.66M | ---- |
| Advance payment increase (decrease) | -147.69%-1.16M | ---- | 174.64%2.42M | ---- | 49.11%-3.25M | ---- | 87.72%-6.38M | ---- | -253.99%-51.93M | ---- |
| prepayments (increase)decrease | -4,830.28%-612.83M | ---- | -111.00%-12.43M | ---- | 118.35%113M | ---- | -210.34%-615.68M | ---- | 132.54%557.96M | ---- |
| Special items for working capital changes | -2,133.58%-12.06B | ---- | -110.15%-539.9M | ---- | 158.50%5.32B | ---- | -217.12%-9.09B | ---- | -18.88%7.76B | ---- |
| Cash from business operations | -29.95%7.86B | -92.29%395.79M | -13.26%11.22B | -48.07%5.13B | 357.05%12.93B | 294.86%9.88B | -372.74%-5.03B | -64.08%-5.07B | 17.59%1.84B | -43.58%-3.09B |
| Other taxs | -15.90%-2.15B | -131.79%-1.32B | 47.72%-1.85B | 77.98%-570.18M | 12.90%-3.55B | 3.63%-2.59B | 5.37%-4.07B | 10.81%-2.69B | ---4.3B | -52.79%-3.01B |
| Interest paid - operating | 16.18%-2.15B | 35.66%-1.17B | 36.03%-2.57B | 10.36%-1.83B | 7.37%-4.02B | -20.54%-2.04B | -29.47%-4.34B | 19.47%-1.69B | 18.66%-3.35B | -31.92%-2.1B |
| Net cash from operations | -47.66%3.56B | -176.78%-2.1B | 26.54%6.79B | -47.95%2.74B | 139.96%5.37B | 155.63%5.26B | -131.43%-13.44B | -15.20%-9.45B | 4.53%-5.81B | -43.51%-8.2B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -56.24%252.41M | -49.00%155.81M | -14.68%576.78M | -6.61%305.5M | 32.27%676.04M | 79.14%327.11M | 6.71%511.12M | -18.65%182.6M | -22.51%478.98M | 61.04%224.46M |
| Dividend received - investment | 368.02%619.51M | ---- | 258.00%132.37M | ---- | -44.81%36.98M | ---- | -94.02%66.99M | ---- | 392.21%1.12B | ---- |
| Loan receivable (increase) decrease | -8.79%-976M | 56.39%-397.11M | -413.11%-897.11M | -169.24%-910.5M | -147.53%-174.84M | -187.78%-338.18M | 129.69%367.88M | 132.52%385.25M | -193.35%-1.24B | -208.02%-1.18B |
| Decrease in deposits (increase) | 25.18%77.98M | -99.54%451K | -71.45%62.3M | -1.99%99.02M | 221.76%218.2M | -24.53%101.03M | -157.23%-179.21M | 572.97%133.88M | 222.71%313.13M | 24.46%-28.31M |
| Purchase of fixed assets | -93.07%-34.22M | ---- | 39.34%-17.73M | ---- | 93.64%-29.22M | ---- | -828.47%-459.44M | ---- | 1.05%-49.48M | ---- |
| Sale of subsidiaries | ---- | ---- | 797.78%118.8M | ---- | -30.03%13.23M | ---- | -92.49%18.91M | ---- | --252M | 2,026.41%300M |
| Acquisition of subsidiaries | -120.63%-1.44B | -117.47%-969.6M | 26.92%-651.21M | -27.43%-445.85M | -1,317.26%-891.13M | -65.20%-349.89M | -102.24%-62.88M | -338.34%-211.79M | 406.00%2.81B | -111.81%-48.32M |
| Recovery of cash from investments | -96.10%4.79M | ---- | 665.08%122.85M | ---- | 6.48%16.06M | --102.34M | -92.41%15.08M | ---- | 37.29%198.75M | 64.39%99.33M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | 99.89%-994K | ---- | ---926.99M | ---- |
| Other items in the investment business | 126,780.51%500.39M | -96.22%5.57M | 99.97%-395K | 111.89%147.58M | -2,979.45%-1.16B | -13,142.20%-1.24B | 95.04%-37.51M | -56.78%9.52M | -4,542.13%-756.16M | -17.70%22.02M |
| Net cash from investment operations | -79.26%-991.9M | -49.81%-1.2B | 57.10%-553.34M | 42.50%-804.25M | -637.53%-1.29B | -380.04%-1.4B | -89.11%239.95M | 181.15%499.45M | -13.68%2.2B | -136.65%-615.46M |
| Net cash before financing | -58.92%2.56B | -271.11%-3.31B | 52.99%6.24B | -49.92%1.93B | 130.91%4.08B | 143.11%3.86B | -266.21%-13.2B | -1.49%-8.95B | -2.09%-3.6B | -118.48%-8.82B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -12.67%15.66B | -24.94%8.08B | -17.43%17.93B | 15.29%10.76B | -34.15%21.72B | -48.52%9.34B | 32.23%32.97B | -1.70%18.14B | -37.15%24.94B | -8.19%18.45B |
| Refund | 34.25%-17.74B | 15.71%-10.3B | 23.03%-26.98B | 34.30%-12.23B | -20.96%-35.05B | -44.34%-18.61B | -5.00%-28.98B | 22.29%-12.89B | -6.58%-27.6B | -56.60%-16.59B |
| Dividends paid - financing | 38.66%-219.83M | ---84M | -35.37%-358.39M | ---- | 33.32%-264.76M | -48.04%-99.68M | -10.67%-397.07M | ---67.33M | 71.70%-358.79M | ---- |
| Absorb investment income | -79.85%167.09M | --115.71M | -70.41%829.29M | ---- | 21.59%2.8B | 4.29%2.53B | -40.29%2.31B | 242.74%2.43B | 782.77%3.86B | 180.88%708.75M |
| Issuance expenses and redemption of securities expenses | -4,503.18%-10.13B | ---4.5B | ---220M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 24.48%6.5B | 166.71%4B | -25.43%5.22B | -72.68%1.5B | -12.50%7B | -8.52%5.49B | 341.62%8B | 254.04%6B | -184.90%-3.31B | -11,885.19%-3.9B |
| Net cash from financing operations | -60.60%-5.78B | -10,115.20%-2.71B | 5.89%-3.6B | 101.99%27.01M | -127.57%-3.83B | -109.99%-1.36B | 660.22%13.88B | 1,127.41%13.6B | -114.71%-2.48B | -115.11%-1.32B |
| Effect of rate | -190.52%-212.96M | -50,392.89%-191.87M | 17.59%235.27M | -100.13%-380K | -73.27%200.07M | -18.71%294.61M | 387.80%748.41M | -22.26%362.39M | -112.00%-260.05M | 567.00%466.13M |
| Net Cash | -221.91%-3.22B | -406.88%-6.01B | 943.03%2.64B | -21.60%1.96B | -62.91%253.14M | -46.31%2.5B | 111.22%682.44M | 145.89%4.65B | -145.67%-6.08B | -314.59%-10.14B |
| Begining period cash | 9.09%34.51B | 9.09%34.51B | 1.45%31.63B | 1.47%31.63B | 4.81%31.18B | 4.79%31.17B | -17.57%29.75B | -30.76%29.75B | 31.33%36.09B | 56.34%42.96B |
| Cash at the end | -9.94%31.08B | -15.74%28.3B | 9.09%34.51B | -1.11%33.59B | 1.45%31.63B | -2.29%33.97B | 4.81%31.18B | 4.43%34.76B | -30.76%29.75B | 3.14%33.29B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.